These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1490564)

  • 21. [Microcirculation tolerance for physical loading and homeostatic indices in stenocardia].
    Anikin VV; Trotsiuk VV
    Kardiologiia; 1981 Aug; 21(8):92-5. PubMed ID: 7289393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale for treating angina pectoris in patients with heart failure.
    Heikkilä J
    Acta Med Scand Suppl; 1985; 694():166-77. PubMed ID: 2860772
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect on painful and silent myocardial ischemia of the preparations Efox and Efox Long in patients with stenocardia of effort].
    Belousov IuB; Egorova NA; Karasev AV; Upnitskiĭ AA
    Ter Arkh; 1997; 69(9):45-7. PubMed ID: 9411825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasmosorption of low-density lipoproteins on heparin-sepharose columns].
    Konovalov GA; Sinitsyn VV; Vedernikov AIu; Kurdanov KhA; Dobrovol'skiĭ AB
    Ter Arkh; 1988; 60(12):16-21. PubMed ID: 3247647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of nicorandil (SG-75), a new long-acting drug with nitroglycerin effects, in patients with coronary artery disease: improved left ventricular function and regional wall motion and abolition of pacing-induced angina.
    Thormann J; Schlepper M; Kramer W; Gottwik M; Kindler M
    J Cardiovasc Pharmacol; 1983; 5(3):371-7. PubMed ID: 6191134
    [No Abstract]   [Full Text] [Related]  

  • 28. Antianginal drugs for stable angina pectoris.
    Aronow WS
    Ration Drug Ther; 1982 Jan; 16(1):1-7. PubMed ID: 6799985
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemodynamic mechanisms of the antianginal action of a novel vasodilator FK409 in dynamic exercise-induced angina.
    Yokota M; Matsunami T; Kodama Y; Sobue T; Nishinaka Y; Iwase M; Miyahara T; Koide M; Saito H; Shibata S
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):412-22. PubMed ID: 7681502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Microcirculatory effects of hemosorption in patients with stable angina pectoris, based on data from radionuclide imaging].
    Atroshchenko ES; Shagisultanov ER
    Kardiologiia; 1991 Oct; 31(10):25-7. PubMed ID: 1753574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Laser acupuncture in the complex treatment of stenocardia].
    Alliluev IG; Syrkin AL; Pal'tseva IS; Pecherskaia MB; Loshchenov VB; Ignatov AA; Belkina EM; Kramarenko TA; Radzievskiĭ SA; Fisenko VA
    Klin Med (Mosk); 1990 Jul; 68(7):54-6. PubMed ID: 2232649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy of foridon in treating stenocardia patients].
    Kupnovyts'ka IH; Chuklin SM
    Vrach Delo; 1991 Oct; (10):87-9. PubMed ID: 1803758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
    De Rosa ML; Giordano A; Melfi M; Della Guardia D; Ciaburri F; Rengo F
    Int J Cardiol; 1998 Jan; 63(1):27-35. PubMed ID: 9482142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacological basis of anti-anginal therapy. I. Physiopathological and pharmacological aspects (author's transl)].
    Penna M
    Rev Med Chil; 1978 Jul; 106(7):536-7. PubMed ID: 694281
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of propranolol in an acute test and a course of treatment in patients with stenocardia].
    Savvateev KL; Desiatnichenko VM; Romakov AIu; Mazur NA
    Ter Arkh; 1988; 60(2):96-101. PubMed ID: 3368872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
    Mikhaĭlusova MP; Bart BIa; Kulikov SI; Smirnova OL; Anchipolovskaia NG; Mamtsev BN; Dergunova EN
    Ter Arkh; 1997; 69(1):17-20. PubMed ID: 9163041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ["Running" pulse magnetic field in treating stenocardia].
    Orlov LL; Makoeva LD; Pochechueva GA; Arzhanenko OM; Belinskaia TF
    Biofizika; 1996; 41(4):949-52. PubMed ID: 8962896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The long-term physical training of patients with functional class-III stenocardia who have had a myocardial infarct].
    Lipchenko AA; Fomin IuL; Antiuf'ev VF
    Ter Arkh; 1990; 62(11):105-7. PubMed ID: 2094971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effectiveness of digoxin and sidnofarm in the initial stages of chronic circulatory failure].
    Bondarenko IP; Tkachev VA
    Vrach Delo; 1989 Oct; (10):73-5. PubMed ID: 2617991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.